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AbstrAct
Objective To examine how different pathways to 
diagnosis of colorectal cancer may be associated 
with the experience of subsequent care.
Design Patient survey linked to information on 
diagnostic route. English patients with colorectal 
cancer (analysis sample n=6837) who responded 
to a patient survey soon after their hospital 
treatment.
Main outcome measures Odds Ratios and 
adjusted proportions of negative evaluation of 
key aspects of care for colorectal cancer, including 
the experience of shared decision-making 
about treatment, specialist nursing and care 
coordination, by diagnostic route (ie, screening 
detection, emergency presentation, urgent and 
elective general practitioner referral).
Results For 14 of 18 questions, there was 
evidence (p≤0.02) for variation in patient 
experience by diagnostic route, with 6–31 
percentage point differences between routes 
in adjusted proportions of negative experience. 
Emergency presenters were more likely to report a 
negative experience for most questions, including 
those about adequacy of information about 
their diagnosis and sufficient explanation before 
operations. Screen-detected patients were least 
likely to report negative experiences except for 
support from primary care. Patients diagnosed 
through elective primary care referrals were most 
likely to report worse experience for questions 
for which overall variation by route was generally 
small.
Conclusions Screening-detected patients tend 
to report the best and emergency presenters 
the worst experience of subsequent care. 
Improvement efforts can target care integration 
for screening-detected patients and provision of 
information about the diagnosis and treatment of 
emergency presenters.
IntroductIon
Patient experience is increasingly regarded 
as a key outcome of cancer care. In England, 
the current national cancer strategy empha-
sises the importance of considering the care 
experience of patients with cancer ‘on a par 
with clinical effectiveness and safety’, as 
one of six national priorities for improve-
ment.1 However, the predictors of positive 
or negative patient experience are poorly 
understood.
Different pathways to cancer diagnosis 
(otherwise known as ‘diagnostic routes’) 
are associated with variation in clinical 
outcomes.2–4 Because of the importance 
of early events in the cancer journey, 
different diagnostic routes may influence 
the experience of subsequent cancer care. 
This hypothesis is particularly applicable 
to colorectal cancer, which is characterised 
by large proportions of patients who are 
diagnosed through an emergency presenta-
tion and through screening, in addition to 
referred (primary-to-secondary care) routes. 
Understanding of associations between 
diagnostic routes and subsequent care expe-
rience can provide insights into predictors 
of negative patient experience and support 
the development of improvement interven-
tions. However, detailed evidence about the 
presence, direction and size of associations 
between diagnostic pathways and experi-
ence of patients with cancer is lacking.
The English Cancer Patient Experi-
ence Survey (CPES) collects data on the 
experience of recently treated patients 
with cancer.5 Using data from this survey 
linked to information on diagnostic route, 
we aimed to identify how diagnostic path-
ways are associated with the experience 
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of subsequent cancer care in patients with colorectal 
cancer.
Methods
data
We analysed anonymous data on patients with 
colorectal cancer who responded to the Cancer 
Patient Experience Survey 2010—a postal survey of 
patients aged 16 or older who were treated for cancer 
in an National Health Service (NHS) hospital during 
January–March 2010.6 The survey was commissioned 
by the UK Department of Health and carried out by 
Quality Health, a specialist survey provider. A few 
weeks after the patients’ treatment and following 
relevant vital status checks, survey questionnaires 
were posted to patients (with up to two reminders to 
non-respondents); the response rate was 67%.6
We a priori restricted analyses to survey responders 
with a diagnosis of colorectal cancer (International 
Classification of Diseases-10 diagnosis codes C18–
C20). We analysed data on patients with complete 
information on diagnostic route, based on data linkage 
with the Routes-to-Diagnosis data set. Routes-to-diag-
nosis denote different care pathways to the diagnosis 
of cancer (see the Exposure variables section below); 
they are algorithmically derived after linking cancer 
registration, Hospital Episode Statistics, screening 
and Cancer Waiting Times data sets.4 Linkage to 
CPES data was carried out previously by the Public 
Health England (former) National Cancer Intelligence 
Network to support public reporting of data on cancer 
patient experience as detailed previously.7 8
Outcomes
We a priori selected 18 survey questions representing 
major aspects of the patient journey from diagnosis to 
post-treatment care (see table 1). For questions with 
more than two response categories, we defined binary 
Table 1 Patient survey questions on aspects of care experience in patients with colorectal cancer
Question number* synoptic form of question exact question wording
  13 Told diagnosis sensitively How do you feel about the way you were told you had cancer?
  15 Written info on cancer diagnosis When you were told you had cancer, were you given written information about 
the type of cancer you had?
  18 Written info about treatment side-effects Before you started your treatment, were you given written information about 
the side effects of treatment(s)?
  19 Shared decision-making Were you involved as much as you wanted to be in decisions about which 
treatment(s) you would have?
  20 Given name of specialist nurse Were you given the name of a clinical nurse specialist who would be in charge 
of your care?
  21 Ease of contacting specialist nurse How easy was it for you to contact your clinical nurse specialist?
  30 Staff explained operation—before Before you had your operation, did a member of staff explain what would be 
done during the operation?
  32 Staff explained operation—after After the operation, did a member of staff explain how it had gone in a way you 
could understand?
  35 Confidence in hospital doctor Did you have confidence and trust in the doctors treating you?
  40 Confidence in ward nurse Did you have confidence and trust in the ward nurses treating you?
  43 Thought info withheld While you were in hospital did you ever think that the doctors or nurses were 
deliberately not telling you certain things that you wanted to know?
  49 Written info at discharge Were you given clear written information about what you should or should not 
do after leaving hospital?
  51 Self-management info post-discharge Did the doctors or nurses give your family or someone close to you all the 
information they needed to help care for you at home?
  58 Emotional support as out-patient While you were being treated as an outpatient or day case, were you given 
enough emotional support from hospital staff?
  60 Waiting time as out-patient The last time you had an out-patient appointment with a cancer doctor at 
one of the hospitals named in the covering letter, how long after the stated 
appointment time did the appointment start?
  63 Adequate info given to GP As far as you know, was your GP given enough information about your 
condition and the treatment you had at the hospital?
  64 General practice staff support Do you think the GPs and nurses at your general practice did everything they 
could to support you while you were having cancer treatment?
  65 Cancer care integration Did the different people treating and caring for you (such as GP, hospital 
doctors, hospital nurses, specialist nurses, community nurses) work well 
together to give you the best possible care?
*Cancer Patient Experience Survey (2010).
GP, general practitioner
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(positive/negative) experience outcomes, consistent with 
public reporting conventions from the CPES survey.6 7
Exposure variables
Our main exposure variable was diagnostic route, 
comprising, for the purposes of this analysis, four 
routes as previously defined.4
 ► Emergency presentation: a diagnosis of cancer within 28 
days from an emergency hospital admission or Accident 
and Emergency department attendance.
 ► Screening detection: as recorded in NHS Bowel Cancer 
Screening programme records.
 ► Urgent referral for suspected cancer: primary care referral 
for which patients have to be assessed by specialist 
hospital services within 2 weeks (hereafter denoted as 
‘Two-Week-Wait’ (TWW) referral).
 ► Elective primary care referral: primary care referral other 
than TWW one; patients are assessed within routine 
outpatient appointments.
Patients with other (rarer) diagnostic routes were 
excluded from the analysis. Other exposure variables 
included patients’ sex, age (grouped as 16–44, 45–54, 
55–64, 65–74, 75–84 and 85+), deprivation group 
(based on hospital records information included in the 
CPES dataset) and white/non-white ethnicity. We used 
self-reported ethnicity information (based on responses 
to a survey item) as it represents the gold standard for 
assigning ethnicity in routine data9; however, when 
self-reported information was missing (5%), we used 
ethnicity information as recorded by the hospital. 
Deprivation quintile groups were defined according 
to the Index of Multiple Deprivation 2007 scores of 
lower super output areas of residence, calculated using 
publicly reported cut-off values.10
Analysis
For each of the 18 survey questions, we calculated the 
crude proportions of a negative experience by diag-
nosis route and subsequently used logistic regression 
to examine associations between diagnostic routes 
and patient experience. After calculating crude (unad-
justed) Odds Ratios (ORs) of negative experience of 
care, we estimated ORs adjusted for sociodemographic 
variables (age, gender, ethnicity, deprivation quintile). 
Robust estimators of the standard error were used in 
regression models to account for potential clustering 
of observations within hospitals of treatment. To aid 
interpretation, using the outputs of the regression 
model used for multivariable analysis (above), we addi-
tionally estimated the adjusted proportions of negative 
experience by diagnostic route, assuming that the case 
mix of patients of each route was the same as that of 
the overall analysis sample. All analyses were carried 
out in STATA V.14.0.
results
After excluding cases with missing outcome or expo-
sure variables, the analysis sample comprised 6837 
patients with colorectal cancer (figure 1). Of those 
patients, 16%, 12%, 39% and 33% were diagnosed 
through an emergency presentation, screening, a TWW 
referral or an elective primary care referral, respec-
tively. The observed proportion of patients reporting 
negative experience response options ranged from 
6% (regarding information provided to the patient’s 
general practitioner) to 42% (regarding the provision 
of information to relatives to help care at home after 
discharge from hospital) (table 2).
Table 2 and figure 2 show the association between 
diagnostic routes and reported patient experience for 
the 18 studied items, adjusted for patient characteris-
tics (unadjusted associations are shown in the online 
Supplementary appendices 1 and 2). Across all ques-
tions, screening-detected patients tend to be the ones 
least likely to report a negative experience, followed 
by those diagnosed via a TWW referral and those diag-
nosed via elective referral. Those diagnosed through 
an emergency presentation were generally most likely 
to report a negative experience.
The size of variation in patient experience by diag-
nostic route differed substantially between the ques-
tions (maximum/minimum odds ratio values across 
Figure 1 Analysis sample derivation.
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diagnostic route groups varied between 1.1 and 5.1, 
table 2, penultimate column), with evidence (p<0.02) 
for variation in patient experience by diagnostic route 
for 14/18 questions. The questions with the largest 
variation in experience across routes included items 
about provision of written information about the diag-
nosis, explanation before and after an operation, the 
provision of a named specialist nurse and questions 
about interpersonal care aspects (table 2). Those ques-
tions where the above ordering of associations (screen 
detected, TWW, elective, emergency) was not observed 
were those associated with limited variation in patient 
experience by diagnostic route.
We also observe that across all questions, differ-
ences in patient experience between the TWW and 
the elective referral route were generally small. The 
single question where patients diagnosed via the 
TWW route were most likely to report negative expe-
riences was a question about practice staff support 
(question 64).
Table 2 Crude percentage and adjusted odds ratios of negative experience of care by studied survey question; questions appear in 
descending order of size of variation by diagnostic route (=penultimate column)
Question 
number
synoptic form of 
question
N* n % Negative 
experience 
(crude) n/N
adjusted ORs of negative experience by route† size of 
variation 
by route  
(max OR/
min OR)
P values
(for overall 
variation 
across the 
four studied 
routes)
emergency 
presentation
elective 
referral
Two-
Week-Wait 
referral 
(reference)
screening 
detection
  15 Written info on 
cancer diagnosis
5610 1495
27
2.85 1.29 0.56 5.09 <0.0001
  30 Staff explained 
operation—before
4944 802
16
2.44 1.04 0.53 4.60 <0.0001
  20 Given name of 
specialist nurse
6348 651
10
2.96 1.38 0.76 3.89 <0.0001
  13 Told diagnosis 
sensitively
6689 1025
15
1.93 1.50 0.70 2.76 <0.0001
  35 Confidence in 
hospital doctor
5331 716
13
1.69 1.03 0.63 2.68 <0.0001
  43 Thought info 
withheld
5312 710
13
1.91 1.30 0.98 1.95 <0.0001
  49 Written info at 
discharge
4962 1050
21
1.51 1.03 0.83 1.82 <0.0001
  32 Staff explained 
operation—after
4988 1134
23
1.60 1.05 0.89 1.80 <0.0001
  19 Shared decision 
making
4899 1283
26
1.41 1.19 1 0.85 1.66 0.0001
  40 Confidence in ward 
nurse
5326 1977
37
1.18 1.19 0.79 1.51 0.0001
  18 Written info about 
treatment side 
effects
6080 795
13
1.38 1.26 0.93 1.48 0.0063
  63 Information given to 
general practitioner
5243 328
6
1.18 0.84 0.82 1.44 0.17
  51 Self-management 
info postdischarge 
family/others
4631 1942
42
1.17 1.03 0.81 1.44 0.20
  65 Cancer care 
integration
6347 2389
38
1.20 1.21 0.85 1.42 0.0001
  64 General practice 
staff support
4587 1337
29
1.22 1.34 1.28 1.34 0.0015
  60 Waiting time as 
outpatient
5983 1755
29
1.17 1.15 0.87 1.34 0.012
  21 Ease of contacting 
specialist nurse
5160 1120
22
0.88 1.05 0.89 1.18 0.29
  58 Emotional support 
as outpatient
4529 1176
26
1.07 1.08 0.97 1.11 0.72
  In columns 6-9, values shown in underlined fonts indicate the worst and those in bold fonts the best comparative experience across the four studied routes. In 
column 10 (size of overall variation between routes) bold fonts indicate questions with evidence p≤0.02). 
*N varied by question, ranging from 4529 (emotional staff support as outpatient—Q58) to 6689 (told diagnosis sensitively—Q13) because some questions were 
not applicable to all patients.
†Adjusted for sex, age group, deprivation quintile, white/non-white ethnicity and colon/rectal subsite. 
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Table 3 shows that for the 14 questions with statis-
tical evidence of variation there was between a 6 and 
31 percentage points difference in case-mix adjusted 
proportions of patient reporting negative experience.
dIscussIon
summary of main findings
 We identified variation in key aspects of patient 
experience by diagnostic route among patients with 
colorectal cancer. Asymptomatic detection (through 
screening) was typically associated with the best expe-
rience of subsequent cancer care. Emergency presenta-
tion was associated with substantially worse compara-
tive experience of many aspects of care, including some 
relating to immediate management. Across questions, 
electively referred patients tend to rate their experi-
ence more negatively than TWW-referred patients, 
although such associations tend to be weak.
comparison with the literature
We know of no relevant peer-reviewed studies exam-
ining the impact of diagnostic routes on experience 
of patient with cancer. A recent in-depth review 
failed to identify any formal evidence from popula-
tion-based studies about associations between emer-
gency presentation and patient experience.2 A recent 
study in Danish patients who presented in primary 
care has indicated that those who were referred 
through a ‘fast-track’ pathway (similar to the TWW 
route in our study) tended to be more satisfied than 
those who were referred electively.11 A previous 
study using English cancer patient experience data 
indicated that a greater number of pre-referral 
consultations is associated with poorer experience of 
subsequent care, though this measure of diagnostic 
timeliness does not necessarily correspond to any 
specific diagnostic route.12
strengths and limitations
We used data from a large nationwide sample of 
colorectal patients with cancer, with information 
on diagnostic routes assigned using validated algo-
rithms. Our analysis was adjusted for patient char-
acteristics including sex, age and deprivation status, 
minimising concerns about potential confounding 
arising from known associations between these 
sociodemographic variables and diagnostic routes. 
We had no information on stage at diagnosis and 
treatment type, and therefore we were not able to 
explore the potential influence of these factors. The 
survey respondents are recently treated patients 
with cancer, not population-based incident cases. 
This may limit the generalisability of the findings, 
particularly regarding patients diagnosed through 
emergency presentation, who are under-represented 
Figure 2 Adjusted odds ratios of negative experience by diagnostic route. Patients diagnosed through a Two-Week-Wait (TWW) route are the 
reference category. Estimates are shown only for the 14 (of 18) questions with statistical evidence for variation by route in our sample (p≤0.02). Dx, 
diagnosis; GP, general practitioner; O-P, outpatient; Ref, reference group; SE, side-effects; Tx, treatment.
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among the survey responders. However, while we 
may, therefore, underestimate the overall prevalence 
of negative experience, such differences are unlikely 
to bias estimates of associations substantially.13 It 
is possible that, given the importance assigned by 
patients to timely diagnosis, some of the observed 
associations may reflect variation in diagnostic time-
liness than diagnostic route.14 However, we had no 
data on the length of diagnostic intervals to examine 
this question empirically.
Interpretation and implications for policy, practice and 
research
Emergency presentation was strongly associated 
with worse experience of subsequent care for the 
majority of the studied questions. Such associations 
were apparent both for questions relating to reports 
of actual processes of care (eg, whether a patient 
was given written information about the diagnosis) 
and the personal evaluation of the experience (eg, 
whether the patient felt they were told their diag-
nosis sensitively; see tables 2 and 3. These observa-
tions suggest that emergency presenters rate the same 
care processes differently, but also, often, experience 
different care processes. Most patients who are diag-
nosed with colorectal cancer in an emergency context 
will need emergency surgery, and clinical teams may 
tend to prioritise clinical as opposed to interpersonal 
care aspects in such circumstances. However, it 
should additionally be noted that differences are 
also apparent for questions relating to care processes 
expected to occur after the emergency context has 
abated, for example, access to specialist nursing or 
written information at discharge (see figure 2). Audit 
initiatives and further evidence about the immediate 
management of this patient group may help to iden-
tify opportunities for improvement.
Patients detected through screening reported best 
experience of care for all aspects of the patient journey 
that were studied, except for the item on ‘practice 
staff support’. This is explainable, as currently at least, 
there is no formal involvement of primary care in the 
English bowel cancer screening programme. It may be 
appropriate to consider a greater degree of integra-
tion of primary care in care pathways after screening 
detection.
Electively referred patients tended to rate their expe-
riences more negatively than those diagnosed after a 
TWW referral. This may result from a sense of poten-
tial avoidable delay (among electively referred patients), 
consistent with previous evidence indicating that patients 
with cancer report better care experiences if they were 
referred promptly and through fast-track routes, given 
the importance of timely diagnosis for patients.11 12 14 
It is also possible that patients referred onto the TWW 
Table 3 Adjusted percentage of negative experience
Question 
number synoptic form of question
adjusted percentage of patients endorsing a negative experience absolute 
difference across 
routes (max 
adjusted %−min 
adjusted %)
emergency 
presentation
elective 
referral
Two-Week-Wait 
referral
screening 
detection
  15 Written info on cancer diagnosis 45.4 27.4 22.7 14.2 31.2
  30 Staff explained operation—before 29.8 15.4 14.9 8.4 21.4
  20 Given name of specialist nurse 19.8 10.3 7.7 6.0 13.8
  13 Told diagnosis sensitively 21.8 17.8 12.7 9.3 12.5
  35 Confidence in hospital doctor 19.7 13.1 12.8 8.5 11.2
  43 Thought info withheld 19.4 14.0 11.2 11.0 8.4
  49 Written info at discharge 27.6 20.7 20.3 17.5 10.1
  32 Staff explained operation—after 30.3 22.3 21.4 19.5 10.8
  19 Shared decision-making 31.2 27.6 24.4 21.6 9.6
  40 Confidence in ward nurse 39.8 40.0 35.9 30.9 9.1
  18 Written info about treatment side effects 15.3 14.2 11.8 11.1 4.2
  63 Information given to general practitioner 7.6 5.6 6.5 5.5 2.1
  51 Self-management info post-discharge 
family/others
45.5 42.4 41.8 36.9 8.6
  65 Cancer care integration 40.2 40.4 36.0 32.3 8.1
  64 General practice staff support 29.9 31.9 26.0 31.0 5.9
  60 Waiting time as outpatient 31.5 31.1 28.2 25.6 5.9
  21 Ease of contacting specialist nurse 19.8 22.8 22.0 20.1 2.7
  58 Emotional support as outpatient 26.7 26.7 25.3 24.8 1.9
Bold/Italic fonts in the last column denote p≤0.02 for variation across all (four) routes (see also footnote of table 2).
In columns 3-6, underlined values denote the route associated with the worse experience and values in bold fonts the route associated with best 
experience.
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care pathway experience more streamlined care, given 
that such pathways are designed to cater for patients in 
whom a cancer diagnosis is a priori suspected. Short-
ening of diagnostic intervals among patients diagnosed 
after an elective referral might also lead to improve-
ments in care experience.
We conclude that decreasing the proportion of 
patients diagnosed through emergency presentation 
can be expected to improve the experience of cancer 
care. Similarly, increasing the proportion of patients 
who are screening-detected (eg, through increasing 
participation in colorectal cancer screening and reduc-
tion of related sociodemographic inequalities) could 
additionally result in improvements in patient-reported 
outcomes.15 16 Therefore, the findings provide additional 
impetus to efforts to reduce the frequency of diagnosis 
of colorectal cancer through emergency presentations 
and optimise participation in population-based bowel 
cancer-screening programmes. However, appreciable 
improvements in patient experience can be also achieved 
by efforts to improve the organisation and delivery of 
cancer care.
acknowledgements We thank the Department of Health as 
the principal investigator of the Cancer Patient Experience 
Survey 2010, Quality Health as data collector and all NHS 
Acute Trusts in England for provision of data samples. We also 
thank all patients who responded to the survey. We would like 
to acknowledge the essential work of the National Cancer 
Registration and Analysis Service (formerly the National 
Cancer Intelligence Network), without whom we would not 
have any cancer registration or Routes to Diagnosis data. This 
project involves data derived from patient-level information 
collected by the NHS as part of the care and support of 
patients with cancer, collated, maintained, and quality assured 
by the National Cancer Registration and Analysis Service, 
which is part of Public Health England. 
contributors The study was initially conceived by SCM, 
GAA and GL. All authors have further developed the focus 
of the paper in collective discussions and contributed to 
the development of methods of analysis. TS led the data 
analysis, with input from GAA. All authors contributed to 
the interpretation of the findings and the drafting of the 
manuscript and approved its final version.
Funding GL, TS and AH are supported by a Cancer Research 
UK, Advanced Clinician Scientist Fellowship Award to GL 
(C18081/A18180). GL is an associate director (co-investigator) 
of the multi-institutional CanTest Research Collaborative 
funded by a Cancer Research UK Population Research Catalyst 
award (C8640/A23385). 
competing interests None declared.
Patient consent Not required.
ethics approval The research is secondary analysis of 
anonymous previously linked data, requiring no ethics 
approval.
Provenance and peer review Not commissioned; externally 
peer reviewed.
Data sharing statement No additional unpublished data are 
available.
Open access This is an Open Access article distributed 
in accordance with the terms of the Creative Commons 
Attribution (CC BY 4.0) license, which permits others to 
distribute, remix, adapt and build upon this work, for 
commercial use, provided the original work is properly cited. 
See: http:// creativecommons. org/ licenses/ by/ 4. 0/
© Article author(s) (or their employer(s) unless otherwise 
stated in the text of the article) 2018. All rights reserved. 
No commercial use is permitted unless otherwise expressly 
granted.
RefeRenCes
 1  NHS England. Achieving world-class cancer outcomes: taking 
the strategy forward. 2016 https://www. england. nhs. uk/ wp- 
content/ uploads/ 2016/ 05/ cancer- strategy. pdf.
 2 Zhou Y, Abel GA, Hamilton W, et al. Diagnosis of cancer as an 
emergency: a critical review of current evidence. Nat Rev Clin 
Oncol 2017;14:45–56.
 3 McPhail S, Elliss-Brookes L, Shelton J, et al. Emergency 
presentation of cancer and short-term mortality. Br J Cancer 
2013;109:2027–34.
 4 Elliss-Brookes L, McPhail S, Ives A, et al. Routes to diagnosis 
for cancer – determining the patient journey using multiple 
routine data sets. Br J Cancer 2012;107:1220–6.
 5  Quality Health. National cancer patient experience survey 
programme–2010. 2010 https://www. gov. uk/ government/ 
publications/ national- cancer- patient- experience- survey- 
programme- 2010- national- survey- report.
 6  National Health Service. National cancer patient experience 
survey programme 2010. 2010 https://www. quality- health. co. 
significance of this study
What is already known on this topic
 ► We searched Medline for evidence examining 
associations between diagnostic pathways and 
patient-reported evaluations of subsequent experience 
of cancer care (aspects of this search formed part of 
an in-depth review on evidence about the predictors 
and consequences of diagnosis of cancer as an 
emergency (Zhou et al, reference 2). We found no 
studies examining this research question across 
emergency, screening and (fast-track or elective) 
referral routes to diagnosis of cancer.
What this study adds
 ► We document strong evidence for variation in key 
aspects of patient experience by diagnostic route 
among nearly 7000 patients with colorectal cancer. 
Screening detection was the diagnostic route 
associated with the most positive experience for 
nearly all studied questions. Emergency presentation 
was the diagnostic route associated with the most 
negative experience for most studied questions, 
including questions about immediate management.
How might it impact on clinical practice in the 
foreseeable future
 ► Improvements are needed in the management 
of emergency presenters with colorectal cancer, 
particularly regarding provision of information 
about their diagnosis and immediate management. 
Decreasing emergency presentations and increasing 
screening participation would improve both clinical 
outcomes and the care experience of patients with 
colorectal cancer.
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